Transcutaneous power conveyance device

Patent No. US10814137 (titled "Transcutaneous power conveyance device") on Feb 14, 2018. The application was issued on Oct 27, 2020.

What is this patent about?

’137 is related to the field of transcutaneous power delivery for medical devices, specifically for treating physiological disorders through neural modulation. The technology provides a mechanism to transfer energy from an external source to an implanted unit, which then stimulates or inhibits specific nerves—such as the hypoglossal nerve for sleep apnea or the occipital nerve for migraines—to manage conditions like obstructive sleep apnea, hypertension, and chronic headaches.

The underlying idea behind ’137 is the use of a modular, two-part external assembly that separates the disposable interface from the reusable electronics to ensure consistent energy transfer. By integrating a primary induction coil into a flexible, adhesive patch that mechanically locks onto a rigid electronics housing, the system maintains a stable spatial relationship between the power source and the internal implant while allowing the user to easily replace the adhesive component without discarding the expensive processing hardware.

The claims of ’137 focus on a device for treating sleep apnea comprising a flexible carrier designed to fit between a subject's chin and neck, featuring an adhesive on one side and a conductive coil for power transmission. The device is characterized by a mechanical connector that extends from the side of the carrier opposite the adhesive, specifically engineered to be received and held by a receiver on a separate electronics housing.

In practice, the flexible carrier acts as a skin-conforming interface that houses the primary antenna, which is often a double-layer crossover coil designed to minimize parasitic capacitance. The mechanical connector, which may take the form of a rodlike element, bayonet mount, or flexible extension arms, ensures that the electronics housing is not only physically secured but also electrically aligned with the antenna. This physical coupling allows the processor to monitor the degree of coupling between the external and internal coils, enabling the system to detect physiological movements—like the tongue shifting during an apnea event—and adjust power delivery in real-time.

This approach differs from prior solutions by providing a selective mechanical engagement that facilitates both rotation and secure retention without requiring the housing to be permanently fixed to the adhesive. Unlike traditional bulky straps or integrated one-piece patches, this design allows for a low-profile, breathable interface that can be precisely positioned. The use of redundant electrical contacts and circular exposed portions ensures that power and data flow remain uninterrupted even if the housing rotates, providing a robust and user-friendly solution for long-term neuromodulation therapy.

How does this patent fit in bigger picture?

Technical Landscape

In the early 2010s when ’137 was filed, transcutaneous power transfer for medical implants was typically implemented using rigid external controllers or bulky inductive coils that required precise, often manual, alignment over the internal receiver. At a time when systems commonly relied on fixed external hardware or cumbersome wearable belts to maintain the inductive link, ensuring consistent energy coupling during patient movement was a significant challenge. Furthermore, when hardware constraints made the integration of power sources and control electronics into a low-profile, patient-adherent form factor non-trivial, most solutions resulted in significant mechanical strain on the skin or frequent decoupling of the power link.

Prosecution Position

The disclosed invention represents a technical advancement in the field of neuromodulation by decoupling the adhesive interface from the primary electronics housing through a modular, two-part architectural shift. By integrating an inductive coil directly into a flexible, adhesive carrier that features a dedicated mechanical connector, the system enables a stable and repeatable alignment between the external power source and the implanted device. This structural solution allows a separate processor housing to be securely mounted to and removed from the carrier, overcoming the constraint of balancing electronic complexity with the need for a lightweight, skin-conformable interface. The resulting technical effect is a robust transcutaneous power link that maintains efficiency during subject activity while facilitating the easy replacement of power or control components without disturbing the primary adhesive site.

Claims

The patent contains a total of 15 claims, with claim 1 serving as the sole independent claim. This independent claim focuses on a sleep apnea treatment device comprising a flexible carrier with an adhesive side, an internal power transmission coil for hypoglossal nerve modulation, and a mechanical connector for attaching an external housing. The dependent claims generally serve to specify various mechanical attachment mechanisms, electrical connection interfaces, housing configurations, and additional coil arrangements for the device.

Key Claim Terms New

Definitions of key terms used in the patent claims.

Term (Source)Support for SpecificationInterpretation
Coil of electrically conductive material
(Claim 1)
A coil of electrically conductive material associated with the flexible carrier is configured for use in transmitting power to an implant to modulate terminal fibers of a hypoglossal nerve. The device is used for conveying power from a location external to a subject to a location within the subject.A conductive winding or inductive element integrated with the carrier that is capable of transcutaneously transmitting electrical power via electromagnetic induction to an implanted component.
Flexible carrier
(Claim 1)
The device may include a flexible carrier, an adhesive on a first side of the carrier, a coil of electrically conductive material associated with the flexible carrier, and a mechanical connector extending from a second side of the carrier opposite the adhesive. The flexible carrier is configured for location between a chin and a neck of the subject.A pliable substrate or support structure designed to conform to the anatomy of a subject's body, specifically the area between the chin and the neck, and serve as a base for an adhesive and an induction coil.
Mechanical connector
(Claim 1)
A mechanical connector extending from a second side of the carrier opposite the adhesive is configured to be received by and retained by a receiver associated with a housing configured for mounting on the carrier. The flexible adhesive patch may include a protrusion extending from a side thereof opposite the adhesive.A physical coupling structure, such as a protrusion, extending from the carrier that is designed to interface with and be held by a corresponding mating component on a separate housing.
Receiver
(Claim 1)
The mechanical connector is configured to be received by and retained by a receiver associated with a housing configured for mounting on the carrier. The device may include a housing configured to contain at least one processor, and a concavity within the housing configured to receive and retain the protrusion extending from the flexible adhesive patch.A structural element, such as a concavity or socket, associated with a processor housing that is configured to accept and secure the mechanical connector of the carrier.
Terminal fibers of a hypoglossal nerve
(Claim 1)
The genioglossus muscle is responsible for forward tongue movement and the stiffening of the anterior pharyngeal wall. In patients with OSA, the neuromuscular activity of the genioglossus muscle is decreased compared to normal individuals. The coil is configured for use in transmitting power to an implant to modulate terminal fibers of a hypoglossal nerve.The distal nerve endings of the hypoglossal nerve that innervate the pharyngeal muscles, such as the genioglossus, targeted for modulation to treat airway obstruction.

Litigation Cases New

US Latest litigation cases involving this patent.

Case NumberFiling DateTitle
1:25-cv-00667May 30, 2025Inspire Medical Systems, Inc. V. Nyxoah, Inc.

Patent Family

Patent Family

File Wrapper

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Get instant alerts for new documents

US10814137

Application Number
US15897107A
Filing Date
Feb 14, 2018
Publication Date
Oct 27, 2020
External Links
Slate, USPTO , Google Patents